Compare
Park Ha Biological Technology Co., Ltd. vs Longevity Health Holdings, Inc. vs Meiwu Technology Co Ltd vs Stepan Co
| Latest fiscal year | Park Ha Biological Technology Co., Ltd. BYAH | Longevity Health Holdings, Inc. XAGE | Meiwu Technology Co Ltd WNW | Stepan Co SCL |
|---|---|---|---|---|
| Year ended | 2025-10-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.52M | $1.91M | $7.08M | $2.33B |
| Revenue growth (YoY) | +6.0% | n/m | n/m | +7.0% |
| Gross margin | 94.4% | 57.2% | 10.1% | 11.6% |
| Operating margin | -956.5% | -371.6% | -124.1% | 3.4% |
| Net margin | -965.0% | -361.0% | -262.5% | 2.0% |
| Net income | -$24.36M | -$6.91M | -$18.59M | $46.90M |
| EPS (Diluted) | -$41.38 | -$4.83 | -$0.82 | $2.05 |
| Operating cash flow | $85.9K | -$3.33M | $9.04M | $147.88M |
| Free cash flow | -$3.0K | -$3.34M | n/a | $25.37M |
| Cash & equivalents | $3.79M | $706.7K | $17.88M | $132.69M |
| Total assets | $5.95M | $2.37M | $50.73M | $2.36B |
| Total liabilities | $1.96M | $8.23M | $1.34M | n/a |
| Shareholders' equity | $3.99M | -$5.87M | $49.39M | $1.24B |
| Return on year-end equity | -609.9% | n/a | -37.6% | 3.8% |
| Shares outstanding | n/a | 1.78M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Park Ha Biological Technology Co., Ltd. | Longevity Health Holdings, Inc. | Meiwu Technology Co Ltd | Stepan Co |
|---|---|---|---|---|
| Latest | $2.52M Ended 2025-10-31 | $1.91M Ended 2025-12-31 | $7.08M Ended 2025-12-31 | $2.33B Ended 2025-12-31 |
| 1 year earlier | $2.38M Ended 2024-10-31 | $50.3K Ended 2024-12-31 | $158.5K Ended 2024-12-31 | $2.18B Ended 2024-12-31 |
| 2 years earlier | $2.46M Ended 2023-10-31 | $0 Ended 2023-12-31 | $10.98M Ended 2023-12-31 | $2.33B Ended 2023-12-31 |
| 3 years earlier | $1.92M Ended 2022-10-31 | n/a | $10.98M Ended 2022-12-31 | $2.77B Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $12.26M Ended 2021-12-31 | $2.35B Ended 2021-12-31 |